共 169 条
[21]
Ohno Y(2015)Effect of vericiguat, a soluble guanylate cyclase stimulator, on natriuretic peptide levels in patients with worsening chronic heart failure and reduced ejection fraction: the SOCRATES-REDUCED randomized trial Jama. 314 2251-2262
[22]
Mitsuma W(2017)Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study Eur Heart J 38 1119-1127
[23]
Tanaka K(2016)A randomized controlled study of finerenone vs. eplerenone in Japanese patients with worsening chronic heart failure and diabetes and/or chronic kidney disease Circ J 80 1113-1122
[24]
Ito M(1990)EuroQol—a new facility for the measurement of health-related quality of life Health Policy 16 199-208
[25]
Ushigome R(2005)The relationship between B-type natriuretic peptide and health status in patients with heart failure J Card Fail 11 414-421
[26]
Sakata Y(2005)Monitoring clinical changes in patients with heart failure: a comparison of methods Am Heart J 150 707-715
[27]
Nochioka K(2002)Estimating an EQ-5D population value set: the case of Japan Health Econ 11 341-353
[28]
Miyata S(1954)A distribution-free k-sample test against ordered alternatives Biometrika. 41 133-145
[29]
Miura M(1979)Intraclass correlations: uses in assessing rater reliability Psychol Bull 86 420-428
[30]
Tadaki S(2002)Generic measures of health-related quality of life in ankylosing spondylitis: reliability, validity and responsiveness Rheumatology. 41 1380-1387